SYRA
Syra Health Corp
$0.5150
+1.98%
No data for this timeframe.
Vol
Inst. Holders5 funds
Inst. Value$14.1K
Inst. Activity1 buys / 1 sells
SEC Reports3
Recent Activity
Jun 5, 2026
SEC
Syra Health Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 1, 2026. The filing contains
DEFA14A — Impact 2/10
May 7, 2026
SEC
Syra Health reported its first profitable quarter in Q1 2026, with net income of $241K compared to a net loss of $472K i
8-K — Impact 7/10
Apr 27, 2026
SEC
Syra Health Corp filed an amended 10-K/A solely to include Part III information (directors, executive compensation, rela
10-K/A — Impact 2/10
Jan 5, 2026
Insider
Alexander Gregory R. was granted 257,920 shares
CEO
Jan 5, 2026
Insider
Alexander Gregory R. was granted 110,537 shares
CEO
Inst.
UBS Group AG — DOUBLED
19,440 shares ($5.1K)
Inst.
BANK OF AMERICA CORP — TRIM
77 shares ($20.00)
May 6, 2026
earnings_calendar
SYRA Q1 2026 Earnings Scheduled — 2026-05-06
Latest Reports
NEUTRAL
DEFA14A
2/10
Syra Health Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 1, 2026. The filing contains
Jun 5, 2026
BULLISH
8-K
7/10
Syra Health reported its first profitable quarter in Q1 2026, with net income of $241K compared to a net loss of $472K i
May 7, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | — | — |
| VANGUARD GROUP INC | $8.9K | TRIM |
| UBS Group AG | $5.1K | DOUBLED |
| CITIGROUP INC | $155.00 | — |
| BANK OF AMERICA CORP | $20.00 | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jan 5, 2026 | Alexander Gregory | A | $0.00 |
| Jan 5, 2026 | Alexander Gregory | A | $0.00 |
5 institutional holders with $14.1K total value (54,593 shares) as of 2025-Q1. Top holders: BARCLAYS, VANGUARD, UBS.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 231 | $0.00 | 0.0% | — |
| 2 | VANGUARD GROUP INC | 34,247 | $8.9K | 63.0% | TRIM -34.1% |
| 3 | UBS Group AG | 19,440 | $5.1K | 35.8% | DOUBLED +1203.8% |
| 4 | CITIGROUP INC | 598 | $155.00 | 1.1% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 77 | $20.00 | 0.1% | TRIM -61.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 1,491 | 19,440 | +1203.8% | $5.1K | 2025-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 201 | 77 | -61.7% | $20.00 | 2025-Q1 |
| VANGUARD GROUP INC | TRIM | 51,975 | 34,247 | -34.1% | $13.7K | 2024-Q4 |
| VANGUARD GROUP INC | ADD | 34,247 | 51,975 | +51.8% | $22.0K | 2024-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 16 | 230 | +1337.5% | $98.00 | 2024-Q3 |
1 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Alexander Gregory R. | CEO | AWARD | 257,920 | — | — |
| Jan 5, 2026 | Alexander Gregory R. | CEO | AWARD | 110,537 | — | — |
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.7/10.
NEUTRAL
DEFA14A
2/10
Syra Health Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 1, 2026.
Jun 5, 2026
BULLISH
8-K
7/10
Syra Health reported its first profitable quarter in Q1 2026, with net income of $241K compared to a
May 7, 2026
NEUTRAL
10-K/A
2/10
Syra Health Corp filed an amended 10-K/A solely to include Part III information (directors, executiv
Apr 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
earnings_calendar
SYRA Q1 2026 Earnings Scheduled — 2026-05-06
Mar 9, 2026
earnings_calendar
SYRA Q4 2025 Earnings Scheduled — 2026-03-09